年轻患者择期开放与腔内腹主动脉瘤修复术围手术期死亡率相当
基于血管质量倡议(VQI)2003-2014年数据,纳入2641例65岁及以下首次择期肾下腹主动脉瘤修复患者,其中EVAR占73%、开放修复占27%。逆概率加权后两组围手术期死亡率绝对值均低于1%(开放0.9% vs EVAR 0.2%,P<.001),加权后生存(HR 0.88,95%CI 0.56-1.38,P=.6)与再干预率无差异,年轻患者中未观察到EVAR优于开放的围手术期死亡及1年生存获益。
要点
- 65岁及以下患者择期肾下腹主动脉瘤修复,开放与EVAR围手术期死亡率均低于1%。
- 加权后两组生存(HR 0.88,95%CI 0.56-1.38)与再干预率无显著差异。
- 年轻患者中未重现EVAR优于开放的围手术期死亡及1年生存获益。
核心结论
- 年轻患者中EVAR与开放修复的围手术期死亡率绝对差异小,未观察到EVAR的围手术期死亡及1年生存优势。
研究设计与样本
- 基于血管质量倡议(VQI)2003-2014年数据,纳入2641例65岁及以下首次择期EVAR或开放肾下腹主动脉瘤修复患者。
- 排除肾旁/胸腹动脉瘤、不适合开放手术及因孤立髂动脉瘤行EVAR者,采用逆概率治疗加权平衡特征。
主要发现
- 未调整围手术期生存率总体99.6%(开放99.1% vs EVAR 99.8%,P<.001),1年生存率总体97.4%(开放97.3% vs EVAR 97.4%,P=.9)。
- 未调整再干预率开放5例、EVAR 7例每100人年(P=.8)。
- 加权后围手术期死亡率开放0.9%、EVAR 0.2%(P<.001),加权生存HR 0.88(95%CI 0.56-1.38,P=.6)。
- 加权后再干预率开放6例、EVAR 8例每100人年(P=.8);70岁以下补充分析结果相似。
临床怎么用
- 年轻肾下腹主动脉瘤患者选择开放或EVAR时,围手术期死亡风险均低,决策需结合长期耐久性而非仅围手术期获益。
局限性
- 随访时间有限(中位401天),长期耐久性数据不足,需进一步研究指导术式选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence for benefit of endovascular aneurysm repair (EVAR) over open surgical repair for de novo infrarenal abdominal aortic aneurysms (AAAs) in younger patients remains conflicting because of heterogeneous study populations and small sample sizes. The objective of this study was to compare perioperative and short-term outcomes for EVAR and open surgery in younger patients using a large national disease and procedure-specific data set. METHODS: We identified patients 65 years of age or younger undergoing first-time elective EVAR or open AAA repair from the Vascular Quality Initiative (2003-2014). We excluded patients with pararenal or thoracoabdominal aneurysms, those medically unfit for open repair, and those undergoing EVAR for isolated iliac aneurysms. Clinical and procedural characteristics were balanced using inverse propensity of treatment weighting. A supplemental analysis extended the study to those younger than 70 years. RESULTS: We identified 2641 patients, 73% (n = 1928) EVAR and 27% (n = 713) open repair. The median age was 62 years (interquartile range, 59-64 years), and 13% were female. The median follow-up time was 401 days (interquartile range, 357-459 days). Unadjusted perioperative survival was 99.6% overall (open repair, 99.1%; EVAR, 99.8%; P < .001), with 97.4% 1-year survival overall (open repair, 97.3%; EVAR, 97.4%; P = .9). Unadjusted reintervention rates were five (open repair) and seven (EVAR) reinterventions per 100 person-years (P = .8). After propensity weighting, the absolute incidence of perioperative mortality was <1% in both groups (open repair, 0.9%, EVAR, 0.2%; P < .001), and complication rates were low. Propensity-weighted survival (hazard ratio, 0.88; 95% confidence interval, 0.56-1.38; P = .6) and reintervention rates (open repair, 6; EVAR, 8; reinterventions per 100 person-years; P = .8) did not differ between the two interventions. The analysis of those younger than 70 years showed similar results. CONCLUSIONS: In this study of younger patients undergoing repair of infrarenal AAA, 30-day morbidity and mortality for both open surgery and EVAR are low, and the absolute mortality difference is small. The prior published perioperative mortality and 1-year survival benefit of EVAR over open AAA repair is not observed in younger patients. Further studies of long-term durability are needed to guide decision-making for open repair vs EVAR in this population.
引用
- Liang NL, Reitz KM, Makaroun MS, et al. Comparable perioperative mortality outcomes in younger patients undergoing elective open and endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2017. PMID: 29097041. doi:10.1016/j.jvs.2017.08.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。